Search research articles
Contact Us
Filters
Showing results (221-230 of 403) with videos related to
Page
of 41
Sort By:
Transplantation and Cellular Therapy
|
January 7, 2024
Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin
Riad El Fakih, Momen Nassani, Walid Rasheed, et al.
Transplantation and Cellular Therapy
|
December 2, 2021
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation
Arnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Bone Marrow Transplantation
|
February 3, 2022
Allogeneic transplant compared to pediatric-inspired therapy for Philadelphia chromosome-negative adolescent and adult ALL in first complete remission
Alfadil Haroon, Feras Alfraih, Amr Hanbali, et al.
Expert Review of Hematology
|
May 27, 2026
From episodic assessment to comprehensive assessment: integrating real-world monitoring in relapsed/refractory multiple myeloma
Carmel Awadallah, Shebli Atrash, Barry Paul, et al.
Transplantation and Cellular Therapy
|
June 14, 2021
Full Dose Cyclophosphamide with the Addition of Fludarabine for Matched Sibling Transplants in Severe Aplastic Anemia
Riad El Fakih, Saud Alhayli, Syed Osman Ahmed, et al.
Hemasphere
|
October 19, 2022
CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete Remission
Mohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Bone Marrow Transplantation
|
February 1, 2023
Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT
Sebastian Giebel, Myriam Labopin, Gerard Socié, et al.
Cancer
|
October 29, 2020
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Giorgia Battipaglia, Myriam Labopin, Rose-Marie Hamladji, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 15, 2016
Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations
Junya Kanda, Ruta Brazauskas, Zhen-Huan Hu, et al.
Bone Marrow Transplantation
|
August 2, 2024
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT
Rama Al Hamed, Myriam Labopin, Depei Wu, et al.
Page
of 41
Search research articles
Search
Showing results (221-230 of 403) with videos related to
Sort By:
Page
of 41
Transplantation and Cellular Therapy
|
January 7, 2024
Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin
Riad El Fakih, Momen Nassani, Walid Rasheed, et al.
Transplantation and Cellular Therapy
|
December 2, 2021
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation
Arnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Bone Marrow Transplantation
|
February 3, 2022
Allogeneic transplant compared to pediatric-inspired therapy for Philadelphia chromosome-negative adolescent and adult ALL in first complete remission
Alfadil Haroon, Feras Alfraih, Amr Hanbali, et al.
Expert Review of Hematology
|
May 27, 2026
From episodic assessment to comprehensive assessment: integrating real-world monitoring in relapsed/refractory multiple myeloma
Carmel Awadallah, Shebli Atrash, Barry Paul, et al.
Transplantation and Cellular Therapy
|
June 14, 2021
Full Dose Cyclophosphamide with the Addition of Fludarabine for Matched Sibling Transplants in Severe Aplastic Anemia
Riad El Fakih, Saud Alhayli, Syed Osman Ahmed, et al.
Hemasphere
|
October 19, 2022
CNS Involvement at Initial Diagnosis and Risk of Relapse After Allogeneic HCT for Acute Lymphoblastic Leukemia in First Complete Remission
Mohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Bone Marrow Transplantation
|
February 1, 2023
Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT
Sebastian Giebel, Myriam Labopin, Gerard Socié, et al.
Cancer
|
October 29, 2020
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Giorgia Battipaglia, Myriam Labopin, Rose-Marie Hamladji, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 15, 2016
Graft-versus-Host Disease after HLA-Matched Sibling Bone Marrow or Peripheral Blood Stem Cell Transplantation: Comparison of North American Caucasian and Japanese Populations
Junya Kanda, Ruta Brazauskas, Zhen-Huan Hu, et al.
Bone Marrow Transplantation
|
August 2, 2024
Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT
Rama Al Hamed, Myriam Labopin, Depei Wu, et al.
Page
of 41